Profil
Daisuke Morishita is associated with Chordia Therapeutics, Inc. as the Chief Scientific Officer since 2017.
He is the founder of Chordia Therapeutics, Inc. which was founded in 2017.
Aktive Positionen von Daisuke Morishita
| Unternehmen | Position | Beginn |
|---|---|---|
| CHORDIA THERAPEUTICS INC. | Gründer | 12.10.2017 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Chordia Therapeutics, Inc.
 Chordia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chordia Therapeutics, Inc. engages in the research and development of novel therapies for cancers. It handles research and development of low-molecular-weight drugs with unprecedented new mechanisms of action in the oncology area. The company was founded by Hiroshi Miyake and Daisuke Morishita on October 12, 2017 and is headquartered in Fujisawa, Japan. | Health Technology |
